Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001957799-24-000313
Filing Date
2024-11-08
Accepted
2024-11-08 16:38:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2883
  Complete submission text file 0001957799-24-000313.txt   4437
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Subject) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36569 | Film No.: 241441291
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA NY 01862
Business Address
Heino Mary Anne (Reporting) CIK: 0001610676 (see all company filings)

Type: 144